Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 34.91B | 33.42B | 28.19B | 26.32B | 25.98B | 25.42B |
Gross Profit | 22.50B | 20.57B | 19.77B | 19.92B | 19.52B | 19.27B |
EBITDA | 15.90B | 13.36B | 14.80B | 12.17B | 11.30B | 13.00B |
Net Income | 6.62B | 4.09B | 6.72B | 6.55B | 5.89B | 7.26B |
Balance Sheet | ||||||
Total Assets | 87.90B | 91.84B | 97.15B | 65.12B | 61.16B | 62.95B |
Cash, Cash Equivalents and Short-Term Investments | 8.03B | 11.97B | 10.94B | 9.30B | 8.04B | 10.65B |
Total Debt | 56.20B | 60.10B | 64.61B | 38.95B | 33.98B | 33.45B |
Total Liabilities | 80.47B | 85.96B | 90.92B | 61.46B | 54.47B | 53.54B |
Stockholders Equity | 7.43B | 5.88B | 6.23B | 3.66B | 6.70B | 9.41B |
Cash Flow | ||||||
Free Cash Flow | 10.61B | 10.39B | 7.36B | 8.79B | 8.38B | 9.89B |
Operating Cash Flow | 12.01B | 11.49B | 8.47B | 9.72B | 9.26B | 10.50B |
Investing Cash Flow | -1.45B | -1.05B | -26.20B | -6.04B | 733.00M | -5.40B |
Financing Cash Flow | -11.84B | -9.41B | 21.05B | -4.04B | -8.27B | -4.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $196.23B | 12.11 | 33.49% | 4.12% | 2.00% | 20.01% | |
73 Outperform | $135.09B | 12.64 | 12.10% | 7.20% | 14.72% | ― | |
72 Outperform | $111.94B | 11.32 | 7.17% | 4.86% | -9.32% | 120.62% | |
69 Neutral | $146.96B | 22.33 | 99.14% | 3.43% | 13.10% | 110.67% | |
68 Neutral | $89.80B | 17.80 | 28.96% | 5.58% | 2.57% | ― | |
68 Neutral | $139.09B | 22.30 | 32.08% | 2.80% | 3.69% | 501.26% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |